SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-20-019739
Filing Date
2020-10-21
Accepted
2020-10-21 16:15:13
Documents
11
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 140144
2 ex3-2.htm EX-3.2 1233
3 ex3-3.htm EX-3.3 2050
4 ex3-13.htm EX-3.13 2048
5 ex31-1.htm EX-31.1 5880
6 ex31-2.htm EX-31.2 5595
7 ex3-2_001.jpg GRAPHIC 116078
8 ex3-3_001.jpg GRAPHIC 217484
9 ex3-3_002.jpg GRAPHIC 153741
10 ex3-13_001.jpg GRAPHIC 231595
11 ex3-13_002.jpg GRAPHIC 59002
  Complete submission text file 0001493152-20-019739.txt   1229629
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36268 | Film No.: 201250710
SIC: 2835 In Vitro & In Vivo Diagnostic Substances